Escherichia coli-derived virus-like particles in vaccine development.
about
Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.Progress in biopharmaceutical development.Lessons from bacteriophages part 1: Deriving utility from protein structure, function, and evolution.
P2860
Escherichia coli-derived virus-like particles in vaccine development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Escherichia coli-derived virus-like particles in vaccine development.
@en
Escherichia coli-derived virus-like particles in vaccine development.
@nl
type
label
Escherichia coli-derived virus-like particles in vaccine development.
@en
Escherichia coli-derived virus-like particles in vaccine development.
@nl
prefLabel
Escherichia coli-derived virus-like particles in vaccine development.
@en
Escherichia coli-derived virus-like particles in vaccine development.
@nl
P2093
P2860
P1433
P1476
Escherichia coli-derived virus-like particles in vaccine development.
@en
P2093
Ningshao Xia
Qinjian Zhao
Xiaofen Huang
P2860
P2888
P356
10.1038/S41541-017-0006-8
P577
2017-02-09T00:00:00Z